Generic Name and Formulations:
Ethacrynic acid 25mg; scored tabs.
Valeant Pharmaceuticals, Inc
Indications for EDECRIN:
Treatment of edema when greater diuretic potential is required.
Initially 50–100mg daily; adjust in 25–50mg increments. Usual maintenance: 50–200mg daily or intermittently.
See Contraindications. Initially 25mg; adjust gradually in 25mg increments (see literature).
Anuria. Infants. If severe, watery diarrhea occurs, discontinue use and do not restart.
Renal impairment. Hepatic cirrhosis. Monitor weight, renal function, electrolytes, CO2, BUN. Potassium supplementation may be needed. Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
Digitalis, lithium toxicity. May alter excretion of lithium. Potentiates warfarin. Antagonized by NSAIDs. Orthostatic hypotension with antihypertensives. Ototoxicity with aminoglycosides, other ototoxic agents. May alter glucose tolerance tests.
GI upset, anorexia, malaise, abdominal pain, dysphagia, ototoxicity, vertigo, headache, rash, electrolyte imbalance, hyperuricemia, gout, hyperglycemia; rare: agranulocytosis, severe neutropenia, thrombocytopenia.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|